Board Member
Context Therapeutics Inc. (CNTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Context Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get CNTX alertsMartin Lehr is recorded as Board Member at Context Therapeutics Inc. (CNTX) since January 1, 2015 and CEO at Context Therapeutics Inc. (CNTX). The newest filing on record that lists Martin Lehr as CEO and Board Member at Context Therapeutics Inc. (CNTX) is dated April 28, 2026. The proxy statement of Context Therapeutics Inc. reports total compensation of $1,465,430 for Martin Lehr in fiscal 2025, including a base salary of $588,515. Disclosed compensation is on record for 6 fiscal years. Martin Lehr has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Context Therapeutics Inc. on June 15, 2026. Context Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Context Therapeutics Inc. includes Andy Pasternak (Chairman and Board Member), Jennifer Minai-Azary (CFO), Dr. Karen L. Smith (Board Member) and 6 others.
“At Context, our mission is to advance bioselective T-cell engagers to address solid tumors where meaningful therapeutic options remain limited.”
“Good morning, everyone, and thank you to Jeffries for hosting myself and our CFO, Gemini, to this wonderful conference. It's my pleasure to introduce Context Therapeutics and our pipeline of T-cell-engaging bispecific antibodies for solid tumors.”
2015-01-01–present
Last confirmed April 28, 2026
Start not stated–present
Last confirmed April 28, 2026
Biotechnology · Healthcare
CEO, Board Member
2015-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Context Therapeutics Inc. (CNTX) | Chief Executive Officer | $588,515 | $1,465,430 |
| 2024 | Context Therapeutics Inc. (CNTX) | Chief Executive Officer | $506,268 | $1,011,069 |
| 2023 | Context Therapeutics Inc. (CNTX) | Chief Executive Officer | $491,522 | $860,681 |
| 2022 | Context Therapeutics Inc. (CNTX) | Chief Executive Officer | $476,625 | $1,057,653 |
| 2021 | Context Therapeutics Inc. (CNTX) | Chief Executive Officer | $291,208 | $1,587,791 |
| 2020 | Context Therapeutics Inc. (CNTX) | Chief Executive Officer | $250,000 | $250,000 |
